Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PR203
- Development stage
- Preclinical
- Lead developer
- Boan Biotech
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Subcutaneous
01
Overview
PR203 is a bispecific antibody developed by Shandong Boan Biotechnology that simultaneously targets TL1A (Tumor necrosis factor superfamily member 15) and IL-23p19 (Interleukin-23 subunit alpha). The drug is designed to block both TL1A and IL-23 signaling pathways to reduce intestinal inflammation more effectively than monotherapies. PR203 features a novel 1+1 format with Fc engineering for half-life extension, which may enable quarterly administration. The anti-TL1A component was derived from the BA-huMab® platform and binds to a unique epitope with high neutralizing activity. Currently in the preclinical stage, PR203 is being investigated for the treatment of inflammatory bowel disease (IBD), psoriasis, and psoriatic arthritis, with a high-concentration formulation developed for subcutaneous administration.
02
Targets
Beyond the preview
Go deeper on PR203.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PR203.